All locations
| Company | Sector & Purpose | Updated | Following |
|---|---|---|---|
|
Abbvie
|
Biopharmaceutical
To discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow
|
2025-Q2
|
|
|
Abbott Laboratories
|
Healthcare
To help people live their best possible life through the power of health
|
2025-Q3
|
|
|
Alnylam Pharmaceuticals
|
Biotechnology
To transform the lives of people afflicted with rare genetic diseases by translating RNA interference into a whole new class of innovative medicines
|
2025-Q3
|
|
|
Albemarle
|
Specialty Chemicals
To enable a sustainable energy future by transforming essential resources into value-added solutions
|
2025-Q3
|
|
|
3m
|
Industrial Conglomerate
Apply science to improve lives and help solve the world's toughest challenges
|
2025-Q3
|
|
|
Air Products And Chemicals
|
Industrial Gases
To serve customers by providing productive solutions through innovative gas, equipment and services that help improve quality of life globally
|
2025-Q3
|
|
|
Aldeyra Therapeutics
|
Biotechnology
To discover, develop and commercialize novel therapies to treat immune-mediated diseases
|
2025-Q3
|
|
|
Acadia Pharmaceuticals
|
Biopharmaceuticals
To advance breakthrough medicines that meaningfully improve the lives of patients with central nervous system disorders
|
2025-Q3
|
|
|
Adma Biologics
|
Biopharmaceuticals
To manufacture, market and develop specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases
|
2025-Q3
|
|
|
Agios Pharmaceuticals
|
Biopharmaceutical
To transform the lives of patients with genetically defined diseases through scientific leadership in cellular metabolism
|
2025-Q3
|
|
|
Akebia Therapeutics
|
Biopharmaceutical
To better the lives of people impacted by kidney disease by advancing innovative therapies
|
2025-Q3
|
|
|
Alector
|
Biotechnology
To develop innovative immunotherapies for neurodegenerative diseases by harnessing the brain's immune system
|
2025-Q3
|
|
|
Adc Therapeutics Sa
|
Biotechnology
To develop and deliver innovative antibody drug conjugates to transform treatment for cancer patients globally
|
2025-Q3
|
|
|
Absci
|
Biotechnology
To create better biologics through the power of artificial intelligence and synthetic biology
|
2025-Q3
|
|
|
Allogene Therapeutics
|
Biotechnology
To develop transformative allogeneic CAR T cell therapies to treat cancer patients
|
2025-Q3
|
|
|
Alkermes
|
Biopharmaceuticals
To develop innovative medicines that make a difference for people living with debilitating diseases
|
2025-Q3
|
|
|
4d Molecular Therapeutics
|
Biotechnology
To transform medicine by advancing next-generation gene therapies using novel AAV vectors to treat genetic diseases
|
2025-Q3
|
|
|
Advansix
|
Specialty Chemicals
To be the leading producer of Nylon 6 resin and chemical intermediates
|
2025-Q3
|
|
|
89bio
|
Biotechnology
To develop innovative therapies for patients with liver and cardio-metabolic diseases
|
2025-Q3
|
|
|
Akero Therapeutics
|
Biotechnology
To develop and commercialize transformational treatments for patients with serious metabolic diseases
|
2025-Q3
|
Page 1 of 4
Showing 1 to 20 of 77 analyses